key: cord-0868722-z9rwkeor authors: Bayyoud, Tarek; Iftner, Angelika; Iftner, Thomas; Bartz-Schmidt, Karl Ulrich; Ueffing, Marius; Schindler, Michael; Thaler, Sebastian title: Absence of Severe Acute Respiratory Syndrome-Coronavirus-2 RNA in ocular tissues date: 2020-06-30 journal: Am J Ophthalmol Case Rep DOI: 10.1016/j.ajoc.2020.100805 sha: daae80dd0ebe133ee9e6fe96184abb0012b3d8d0 doc_id: 868722 cord_uid: z9rwkeor PURPOSE: To evaluate the status of ocular donor tissues of a COVID-19 postmortem donor. METHODS: SARS-CoV-2 was detected via a pharyngeal swab and broncho-alveolar lavage in the COVID-19 suspect. Postmortem tissue procurement and preparation were performed with personal protective equipment (PPE) and the necessary protective measures. qRT-PCR-testing was performed for the following ocular tissues and fluids: conjunctival fluid swabs, bulbar conjunctiva, corneal epithelium, corneal stroma, corneal endothelium, anterior chamber fluid, lens, iris, vitreous, retina, uvea, sclera, and optic nerve. Informed consent and Institutional Review Board approval was obtained prior to this study (196/2020BO2; Date of approval: 03/26/2020; Ethics Committee of the University of Tuebingen). RESULTS: In all ocular tissue and fluid samples no SARS-CoV-2 RNA was detected via qRT-PCR of the confirmed COVID-19 postmortem donor. CONCLUSIONS: and Importance: Late-stage COVID-19 patients might not harbor an ocular reservoir of SARS-CoV-2. The risk of transmitting SARS-CoV-2 via ocular tissues and fluids might be low. This may bear future implications for patient management in ophthalmological practice, surgery and transplantation. documented. In addition, the place of enucleation is not allowed to be used by 105 another person at the time of tissue extraction. Any kind of aerosol and/ or turbulence 106 has to be prevented by the performing person. The necessary equipment has to be 107 discarded after usage and/ or disinfected depending on the specific utensils used. To 108 preclude any kind of self-harm personal protective equipment (PPE) has to be used 109 appropriately. This includes gowns (overalls and apron), double gloves (as indicator Reaction 124 125 The RNA extraction and qRT-PCR was performed using RealStar SARS-CoV-2 RT-126 We report here the absence of SARS-CoV-2 RNA in ocular tissues obtained from a 132 COVID-19 postmortem donor using qRT-PCR on the following tissues: conjunctival 133 fluid swabs, bulbar conjunctiva, corneal epithelium, corneal stroma, corneal 134 endothelium, anterior chamber fluid, lens, iris, vitreous, retina, uvea, sclera, and optic 135 nerve. All tissue samples tested negative for SARS-CoV-2 viral RNA coding for its S 136 and E genes, indicating absence of viral infection in the eye. increased risk for infection may exist 8 . This study is considered early stage pilot and 7 was used to test the design. In order to confirm or refute the preliminary data a full-156 scale study needs to be implemented. 157 158 Although limited to a single patient, our findings suggest that late-stage COVID-19 160 patients do not carry an ocular reservoir of SARS-CoV-2. This bears implications for 161 the management of COVID-19 patients in ophthalmological emergency and general 162 surgery and, in particular, for tissue procurement and processing of potential COVID-163 19 donors as well as corneal transplantation surgery. Nevertheless, until more 164 extensive studies are available, protective measures need to be maintained. 165 166 Written consent was obtained prior to the study. A novel coronavirus outbreak of global 183 health concern Humans, Viruses, and the Eye-An Early Report From the 2019-nCoV transmission through the ocular surface must 190 not be ignored Haemorrhagic conjunctivitis with 193 pseudomembranous related to SARS-CoV-2 Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-202 Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors CoV-2) and Colonization of Ocular Tissues and Secretions: A Systematic Review 207 Conflicts of Interest Statements: Tarek Bayyoud, MD: Conflicts of interest: none Conflicts of interest: none PhD: Conflicts of interest: none MD: Conflicts of interest: none PhD: Conflicts of interest: none PhD: Conflicts of interest: none MD: Conflicts of interest: none Eye (Lond) . 2020 May 18;1-6. doi: 10.1038/s41433-020-0926-9 . Online ahead of 208 print. This was followed by the inspection of body bag and corpus, preparation of transport 221 media and vessel (left globe: sterile gauze, 10mL NaCl, 10 mL gentamicinsulfate 222 (5mg/mL); right globe: sterile gauze, 10mL NaCl; each vessel marked: COVID-19 223 donor tissues R or L). Flushing of the superior and inferior fornix of the left globe 224 (Betaisodona ® ; 1:10 diluted in sterile NaCl equivalent to 1% of free iodine, flushing 225 with sterile NaCl after 5 min) ensued with prior periocular wiping with Betaisodona ® . 226The right globe was kept naïve. The provided drape, vessel and PPE was used 227 appropriately to prevent any kind of self-harm. The process of enucleation was done 228 with single-use surgical set (eyelid blocker, forceps, scissors, hooks) to obtain an 229 intact globe with conjunctivae (5-10mm) and prevent any potential contaminations. 230Prosthesis selection, insertion and closure of palpebral fissures ensued. The transfer 231 of each globe into the pre-defined transport vessel and a marked re-lockable 232 container followed (marked: "COVID-19 donor tissues"). Final disposal of the used 233 10 PPE and potentially infectious materials was performed to current standards of 234 hygiene and occupational safety. The transport took place via a re-lockable, marked 235 container ("COVID-19 donor tissues") during which temperature was recorded and 236 kept between 33.8°F to 50°F (+1 to +10°C) using cooling packs and a cooling box Kolibri-forceps, Vannas-scissors, Westcott-scissors, hockey knife and vacuum 245 holder) and extraction of tissue/ fluid samples for quantitative Reverse Transcription-246Polymerase Chain Reaction (qRT-PCR) testing on SARS-CoV-2 RNA was done to 247 the highest standards of bio-banking to obtain bulbar conjunctiva, corneal epithelium, 248 corneal stroma, corneal endothelium, anterior chamber fluid, lens, iris, vitreous, 249 retina, uvea, sclera, and optic nerve samples. 250